New approach to drug discovery could lead to personalised treatment of neuropsychiatric disorders

Researchers from our Centre for Neuropsychiatric Research have developed a method that could drastically accelerate the search for new drugs to treat mental health disorders such as schizophrenia.

Research led by Professor Sabine Bahn has shown that live blood cells from patients with mental health disorders can be used to identify potential targets for drug discovery research.

Their results are reported in the journal Science Advances: Santiago G. Lago et al. ‘Drug discovery for psychiatric disorders using high-content single-cell screening of signalling network responses ex vivo.’ Science Advances (2019). DOI: 10.1126/sciadv.aau9093

pharma,mental health,schizophrenia,drug discovery,biotechnology,science,